MSB Trading - 2020, page-20230

Only you are thinking differently with your blinkers on.

The price has factored in some small chance that covid ARDS will be approved that is for sure which is why the share price has increased x3 since March.

It isn't all because aGVHD and CHF are in phase 3 trials only.

If you note their comments, they said everyone should have a holding albeit a "small holding". That is the sensible thing to do at this stage.

Also, like i had said many times earlier we need luck and hope that the ones on placebo die; as you read they have said it is very difficult now to get FDA approval with more patients living. You can clearly see the SOC has increased dramatically since the start of the year. You are not seeing the 85% mortality rate anymore. In fact a logical % would be 50% for those receiving SOC but could be as high as 70% and increasing each day as doctors find the best way to treat patients.

But we still have a chance, it's a gamble after all.